nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—Corticosteroid Hormone Receptor Agonists—Prednisone—systemic scleroderma	0.24	1	CiPCiCtD
Triamcinolone—Mometasone—systemic scleroderma	0.147	0.647	CrCtD
Triamcinolone—Prednisone—systemic scleroderma	0.08	0.353	CrCtD
Triamcinolone—ankylosing spondylitis—systemic scleroderma	0.0664	0.277	CtDrD
Triamcinolone—systemic lupus erythematosus—systemic scleroderma	0.0633	0.264	CtDrD
Triamcinolone—rheumatoid arthritis—systemic scleroderma	0.0598	0.25	CtDrD
Triamcinolone—NR3C1—Mometasone—systemic scleroderma	0.0545	0.705	CbGbCtD
Triamcinolone—psoriasis—systemic scleroderma	0.0501	0.209	CtDrD
Triamcinolone—NR3C1—Prednisone—systemic scleroderma	0.0174	0.224	CbGbCtD
Triamcinolone—Fluticasone furoate—Mometasone—systemic scleroderma	0.00499	0.0296	CrCrCtD
Triamcinolone—Flumethasone Pivalate—Mometasone—systemic scleroderma	0.00449	0.0266	CrCrCtD
Triamcinolone—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00434	0.0257	CrCrCtD
Triamcinolone—Halobetasol Propionate—Mometasone—systemic scleroderma	0.00434	0.0257	CrCrCtD
Triamcinolone—Difluprednate—Mometasone—systemic scleroderma	0.00434	0.0257	CrCrCtD
Triamcinolone—Fluocinonide—Mometasone—systemic scleroderma	0.00408	0.0242	CrCrCtD
Triamcinolone—Prednicarbate—Mometasone—systemic scleroderma	0.00408	0.0242	CrCrCtD
Triamcinolone—Testolactone—Mometasone—systemic scleroderma	0.00408	0.0242	CrCrCtD
Triamcinolone—Beclomethasone—Mometasone—systemic scleroderma	0.00408	0.0242	CrCrCtD
Triamcinolone—Clocortolone—Mometasone—systemic scleroderma	0.00408	0.0242	CrCrCtD
Triamcinolone—Fluocortolone—Mometasone—systemic scleroderma	0.00397	0.0235	CrCrCtD
Triamcinolone—Alclometasone—Mometasone—systemic scleroderma	0.00386	0.0229	CrCrCtD
Triamcinolone—Fluocinolone Acetonide—Mometasone—systemic scleroderma	0.00386	0.0229	CrCrCtD
Triamcinolone—Budesonide—Mometasone—systemic scleroderma	0.00375	0.0222	CrCrCtD
Triamcinolone—Amcinonide—Mometasone—systemic scleroderma	0.00375	0.0222	CrCrCtD
Triamcinolone—Fluoxymesterone—Mometasone—systemic scleroderma	0.00375	0.0222	CrCrCtD
Triamcinolone—Flunisolide—Mometasone—systemic scleroderma	0.00366	0.0217	CrCrCtD
Triamcinolone—Clobetasol propionate—Mometasone—systemic scleroderma	0.00366	0.0217	CrCrCtD
Triamcinolone—Desonide—Mometasone—systemic scleroderma	0.00366	0.0217	CrCrCtD
Triamcinolone—Fludrocortisone—Mometasone—systemic scleroderma	0.00366	0.0217	CrCrCtD
Triamcinolone—Prednisone—Mometasone—systemic scleroderma	0.00366	0.0217	CrCrCtD
Triamcinolone—Diflorasone—Mometasone—systemic scleroderma	0.00366	0.0217	CrCrCtD
Triamcinolone—Paramethasone—Mometasone—systemic scleroderma	0.00356	0.0211	CrCrCtD
Triamcinolone—Desoximetasone—Mometasone—systemic scleroderma	0.00348	0.0206	CrCrCtD
Triamcinolone—Fluorometholone—Mometasone—systemic scleroderma	0.0034	0.0201	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Mometasone—systemic scleroderma	0.0034	0.0201	CrCrCtD
Triamcinolone—Loteprednol—Mometasone—systemic scleroderma	0.0034	0.0201	CrCrCtD
Triamcinolone—Betamethasone—Mometasone—systemic scleroderma	0.00332	0.0197	CrCrCtD
Triamcinolone—Dexamethasone—Mometasone—systemic scleroderma	0.00332	0.0197	CrCrCtD
Triamcinolone—Rimexolone—Mometasone—systemic scleroderma	0.00332	0.0197	CrCrCtD
Triamcinolone—Methylprednisolone—Mometasone—systemic scleroderma	0.00317	0.0188	CrCrCtD
Triamcinolone—Prednisolone—Mometasone—systemic scleroderma	0.00311	0.0184	CrCrCtD
Triamcinolone—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.00303	0.0392	CbGbCtD
Triamcinolone—Hydrocortisone—Mometasone—systemic scleroderma	0.00298	0.0177	CrCrCtD
Triamcinolone—CYP3A4—Prednisone—systemic scleroderma	0.00242	0.0313	CbGbCtD
Triamcinolone—Testolactone—Prednisone—systemic scleroderma	0.00223	0.0132	CrCrCtD
Triamcinolone—Prednicarbate—Prednisone—systemic scleroderma	0.00223	0.0132	CrCrCtD
Triamcinolone—Fluocortolone—Prednisone—systemic scleroderma	0.00216	0.0128	CrCrCtD
Triamcinolone—Alclometasone—Prednisone—systemic scleroderma	0.0021	0.0125	CrCrCtD
Triamcinolone—Budesonide—Prednisone—systemic scleroderma	0.00205	0.0121	CrCrCtD
Triamcinolone—Amcinonide—Prednisone—systemic scleroderma	0.00205	0.0121	CrCrCtD
Triamcinolone—Diflorasone—Prednisone—systemic scleroderma	0.00199	0.0118	CrCrCtD
Triamcinolone—Fludrocortisone—Prednisone—systemic scleroderma	0.00199	0.0118	CrCrCtD
Triamcinolone—Desonide—Prednisone—systemic scleroderma	0.00199	0.0118	CrCrCtD
Triamcinolone—Clobetasol propionate—Prednisone—systemic scleroderma	0.00199	0.0118	CrCrCtD
Triamcinolone—Flunisolide—Prednisone—systemic scleroderma	0.00199	0.0118	CrCrCtD
Triamcinolone—Paramethasone—Prednisone—systemic scleroderma	0.00194	0.0115	CrCrCtD
Triamcinolone—Desoximetasone—Prednisone—systemic scleroderma	0.0019	0.0112	CrCrCtD
Triamcinolone—Fluprednidene Acetate—Prednisone—systemic scleroderma	0.00185	0.011	CrCrCtD
Triamcinolone—Loteprednol—Prednisone—systemic scleroderma	0.00185	0.011	CrCrCtD
Triamcinolone—Fluorometholone—Prednisone—systemic scleroderma	0.00185	0.011	CrCrCtD
Triamcinolone—Mometasone—Prednisone—systemic scleroderma	0.00185	0.011	CrCrCtD
Triamcinolone—Dexamethasone—Prednisone—systemic scleroderma	0.00181	0.0107	CrCrCtD
Triamcinolone—Rimexolone—Prednisone—systemic scleroderma	0.00181	0.0107	CrCrCtD
Triamcinolone—Betamethasone—Prednisone—systemic scleroderma	0.00181	0.0107	CrCrCtD
Triamcinolone—Methylprednisolone—Prednisone—systemic scleroderma	0.00173	0.0103	CrCrCtD
Triamcinolone—Prednisolone—Prednisone—systemic scleroderma	0.00169	0.01	CrCrCtD
Triamcinolone—Hydrocortisone—Prednisone—systemic scleroderma	0.00163	0.00963	CrCrCtD
Triamcinolone—PTGS2—Fluocinonide—Mometasone—systemic scleroderma	0.000329	0.624	CbGdCrCtD
Triamcinolone—PTGS2—skeletal joint—systemic scleroderma	0.000326	0.204	CbGeAlD
Triamcinolone—PTGS2—Fluticasone Propionate—Mometasone—systemic scleroderma	0.000198	0.376	CbGdCrCtD
Triamcinolone—PTGS2—artery—systemic scleroderma	0.000136	0.0855	CbGeAlD
Triamcinolone—PTGS2—endothelium—systemic scleroderma	0.000115	0.0722	CbGeAlD
Triamcinolone—PTGS2—blood vessel—systemic scleroderma	0.000106	0.0666	CbGeAlD
Triamcinolone—SERPINA6—lung—systemic scleroderma	8.67e-05	0.0544	CbGeAlD
Triamcinolone—BCHE—smooth muscle tissue—systemic scleroderma	6.47e-05	0.0406	CbGeAlD
Triamcinolone—BCHE—skin of body—systemic scleroderma	6.38e-05	0.04	CbGeAlD
Triamcinolone—NR3C1—connective tissue—systemic scleroderma	6.29e-05	0.0395	CbGeAlD
Triamcinolone—NR3C1—smooth muscle tissue—systemic scleroderma	5.76e-05	0.0361	CbGeAlD
Triamcinolone—NR3C1—skin of body—systemic scleroderma	5.68e-05	0.0356	CbGeAlD
Triamcinolone—PTGS2—connective tissue—systemic scleroderma	5.45e-05	0.0342	CbGeAlD
Triamcinolone—BCHE—digestive system—systemic scleroderma	5.11e-05	0.032	CbGeAlD
Triamcinolone—PTGS2—smooth muscle tissue—systemic scleroderma	4.98e-05	0.0313	CbGeAlD
Triamcinolone—PTGS2—skin of body—systemic scleroderma	4.92e-05	0.0308	CbGeAlD
Triamcinolone—NR3C1—digestive system—systemic scleroderma	4.55e-05	0.0285	CbGeAlD
Triamcinolone—NR3C1—tendon—systemic scleroderma	4.33e-05	0.0271	CbGeAlD
Triamcinolone—BCHE—lung—systemic scleroderma	4.27e-05	0.0267	CbGeAlD
Triamcinolone—PTGS2—digestive system—systemic scleroderma	3.93e-05	0.0247	CbGeAlD
Triamcinolone—NR3C1—lung—systemic scleroderma	3.8e-05	0.0238	CbGeAlD
Triamcinolone—PTGS2—tendon—systemic scleroderma	3.74e-05	0.0235	CbGeAlD
Triamcinolone—CYP3A4—digestive system—systemic scleroderma	3.44e-05	0.0216	CbGeAlD
Triamcinolone—PTGS2—lung—systemic scleroderma	3.29e-05	0.0206	CbGeAlD
Triamcinolone—Back pain—Lisinopril—systemic scleroderma	2.84e-05	0.000622	CcSEcCtD
Triamcinolone—Vomiting—Pentoxifylline—systemic scleroderma	2.84e-05	0.000621	CcSEcCtD
Triamcinolone—Convulsion—Mycophenolic acid—systemic scleroderma	2.83e-05	0.000618	CcSEcCtD
Triamcinolone—Rash—Pentoxifylline—systemic scleroderma	2.82e-05	0.000616	CcSEcCtD
Triamcinolone—Hypertension—Mycophenolic acid—systemic scleroderma	2.82e-05	0.000616	CcSEcCtD
Triamcinolone—Dermatitis—Pentoxifylline—systemic scleroderma	2.81e-05	0.000616	CcSEcCtD
Triamcinolone—Headache—Pentoxifylline—systemic scleroderma	2.8e-05	0.000612	CcSEcCtD
Triamcinolone—Thrombophlebitis—Methotrexate—systemic scleroderma	2.8e-05	0.000612	CcSEcCtD
Triamcinolone—Anaphylactic shock—Leflunomide—systemic scleroderma	2.79e-05	0.00061	CcSEcCtD
Triamcinolone—Feeling abnormal—Captopril—systemic scleroderma	2.79e-05	0.00061	CcSEcCtD
Triamcinolone—Diabetes mellitus—Methotrexate—systemic scleroderma	2.78e-05	0.000609	CcSEcCtD
Triamcinolone—Myalgia—Mycophenolic acid—systemic scleroderma	2.78e-05	0.000607	CcSEcCtD
Triamcinolone—Infection—Leflunomide—systemic scleroderma	2.77e-05	0.000606	CcSEcCtD
Triamcinolone—Asthenia—Mometasone—systemic scleroderma	2.77e-05	0.000605	CcSEcCtD
Triamcinolone—Cardiac arrest—Prednisone—systemic scleroderma	2.76e-05	0.000603	CcSEcCtD
Triamcinolone—Mood swings—Prednisone—systemic scleroderma	2.75e-05	0.0006	CcSEcCtD
Triamcinolone—Discomfort—Mycophenolic acid—systemic scleroderma	2.74e-05	0.0006	CcSEcCtD
Triamcinolone—Pruritus—Mometasone—systemic scleroderma	2.73e-05	0.000597	CcSEcCtD
Triamcinolone—Ill-defined disorder—Lisinopril—systemic scleroderma	2.73e-05	0.000596	CcSEcCtD
Triamcinolone—Tachycardia—Leflunomide—systemic scleroderma	2.72e-05	0.000596	CcSEcCtD
Triamcinolone—Dry mouth—Mycophenolic acid—systemic scleroderma	2.72e-05	0.000594	CcSEcCtD
Triamcinolone—Hyperhidrosis—Leflunomide—systemic scleroderma	2.7e-05	0.00059	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	2.69e-05	0.000589	CcSEcCtD
Triamcinolone—Angioedema—Lisinopril—systemic scleroderma	2.68e-05	0.000587	CcSEcCtD
Triamcinolone—Body temperature increased—Captopril—systemic scleroderma	2.68e-05	0.000586	CcSEcCtD
Triamcinolone—Oedema—Mycophenolic acid—systemic scleroderma	2.66e-05	0.000582	CcSEcCtD
Triamcinolone—Nausea—Pentoxifylline—systemic scleroderma	2.65e-05	0.000581	CcSEcCtD
Triamcinolone—Malaise—Lisinopril—systemic scleroderma	2.65e-05	0.00058	CcSEcCtD
Triamcinolone—Infection—Mycophenolic acid—systemic scleroderma	2.65e-05	0.000579	CcSEcCtD
Triamcinolone—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	2.64e-05	0.000578	CcSEcCtD
Triamcinolone—Vertigo—Lisinopril—systemic scleroderma	2.64e-05	0.000577	CcSEcCtD
Triamcinolone—Syncope—Lisinopril—systemic scleroderma	2.64e-05	0.000576	CcSEcCtD
Triamcinolone—Shock—Mycophenolic acid—systemic scleroderma	2.62e-05	0.000573	CcSEcCtD
Triamcinolone—Tachycardia—Mycophenolic acid—systemic scleroderma	2.6e-05	0.000568	CcSEcCtD
Triamcinolone—Loss of consciousness—Lisinopril—systemic scleroderma	2.58e-05	0.000565	CcSEcCtD
Triamcinolone—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	2.57e-05	0.000563	CcSEcCtD
Triamcinolone—Cough—Lisinopril—systemic scleroderma	2.56e-05	0.000561	CcSEcCtD
Triamcinolone—Muscular weakness—Prednisone—systemic scleroderma	2.56e-05	0.000559	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	2.54e-05	0.000556	CcSEcCtD
Triamcinolone—Insomnia—Leflunomide—systemic scleroderma	2.52e-05	0.000552	CcSEcCtD
Triamcinolone—Abdominal distension—Prednisone—systemic scleroderma	2.52e-05	0.000551	CcSEcCtD
Triamcinolone—Dysgeusia—Mycophenolate mofetil—systemic scleroderma	2.52e-05	0.000551	CcSEcCtD
Triamcinolone—Paraesthesia—Leflunomide—systemic scleroderma	2.51e-05	0.000548	CcSEcCtD
Triamcinolone—Anaphylactoid reaction—Methotrexate—systemic scleroderma	2.5e-05	0.000547	CcSEcCtD
Triamcinolone—Myalgia—Lisinopril—systemic scleroderma	2.5e-05	0.000547	CcSEcCtD
Triamcinolone—Back pain—Mycophenolate mofetil—systemic scleroderma	2.49e-05	0.000545	CcSEcCtD
Triamcinolone—Dyspnoea—Leflunomide—systemic scleroderma	2.49e-05	0.000544	CcSEcCtD
Triamcinolone—Discomfort—Lisinopril—systemic scleroderma	2.47e-05	0.000541	CcSEcCtD
Triamcinolone—Dyspepsia—Leflunomide—systemic scleroderma	2.46e-05	0.000537	CcSEcCtD
Triamcinolone—Pancreatitis—Prednisone—systemic scleroderma	2.46e-05	0.000537	CcSEcCtD
Triamcinolone—Vomiting—Mometasone—systemic scleroderma	2.45e-05	0.000536	CcSEcCtD
Triamcinolone—Dry mouth—Lisinopril—systemic scleroderma	2.45e-05	0.000535	CcSEcCtD
Triamcinolone—Sweating increased—Prednisone—systemic scleroderma	2.44e-05	0.000534	CcSEcCtD
Triamcinolone—Feeling abnormal—Azathioprine—systemic scleroderma	2.44e-05	0.000533	CcSEcCtD
Triamcinolone—Rash—Mometasone—systemic scleroderma	2.43e-05	0.000532	CcSEcCtD
Triamcinolone—Asthenia—Captopril—systemic scleroderma	2.43e-05	0.000531	CcSEcCtD
Triamcinolone—Dermatitis—Mometasone—systemic scleroderma	2.43e-05	0.000531	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	2.43e-05	0.000531	CcSEcCtD
Triamcinolone—Osteoarthritis—Methotrexate—systemic scleroderma	2.42e-05	0.00053	CcSEcCtD
Triamcinolone—Headache—Mometasone—systemic scleroderma	2.42e-05	0.000528	CcSEcCtD
Triamcinolone—Insomnia—Mycophenolic acid—systemic scleroderma	2.41e-05	0.000527	CcSEcCtD
Triamcinolone—Fatigue—Leflunomide—systemic scleroderma	2.41e-05	0.000526	CcSEcCtD
Triamcinolone—Oedema—Lisinopril—systemic scleroderma	2.4e-05	0.000525	CcSEcCtD
Triamcinolone—Anaphylactic shock—Lisinopril—systemic scleroderma	2.4e-05	0.000525	CcSEcCtD
Triamcinolone—Pruritus—Captopril—systemic scleroderma	2.4e-05	0.000524	CcSEcCtD
Triamcinolone—Paraesthesia—Mycophenolic acid—systemic scleroderma	2.39e-05	0.000523	CcSEcCtD
Triamcinolone—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	2.39e-05	0.000522	CcSEcCtD
Triamcinolone—Pain—Leflunomide—systemic scleroderma	2.39e-05	0.000522	CcSEcCtD
Triamcinolone—Infection—Lisinopril—systemic scleroderma	2.38e-05	0.000521	CcSEcCtD
Triamcinolone—Dyspnoea—Mycophenolic acid—systemic scleroderma	2.37e-05	0.000519	CcSEcCtD
Triamcinolone—Shock—Lisinopril—systemic scleroderma	2.36e-05	0.000516	CcSEcCtD
Triamcinolone—Angioedema—Mycophenolate mofetil—systemic scleroderma	2.35e-05	0.000515	CcSEcCtD
Triamcinolone—Dyspepsia—Mycophenolic acid—systemic scleroderma	2.34e-05	0.000513	CcSEcCtD
Triamcinolone—Tachycardia—Lisinopril—systemic scleroderma	2.34e-05	0.000512	CcSEcCtD
Triamcinolone—Body temperature increased—Azathioprine—systemic scleroderma	2.34e-05	0.000511	CcSEcCtD
Triamcinolone—Malaise—Mycophenolate mofetil—systemic scleroderma	2.32e-05	0.000508	CcSEcCtD
Triamcinolone—Hyperhidrosis—Lisinopril—systemic scleroderma	2.32e-05	0.000507	CcSEcCtD
Triamcinolone—Vertigo—Mycophenolate mofetil—systemic scleroderma	2.31e-05	0.000506	CcSEcCtD
Triamcinolone—Syncope—Mycophenolate mofetil—systemic scleroderma	2.31e-05	0.000505	CcSEcCtD
Triamcinolone—Feeling abnormal—Leflunomide—systemic scleroderma	2.3e-05	0.000503	CcSEcCtD
Triamcinolone—Fatigue—Mycophenolic acid—systemic scleroderma	2.3e-05	0.000502	CcSEcCtD
Triamcinolone—Mood swings—Methotrexate—systemic scleroderma	2.29e-05	0.000502	CcSEcCtD
Triamcinolone—Nausea—Mometasone—systemic scleroderma	2.29e-05	0.000501	CcSEcCtD
Triamcinolone—Weight increased—Prednisone—systemic scleroderma	2.28e-05	0.000499	CcSEcCtD
Triamcinolone—Pain—Mycophenolic acid—systemic scleroderma	2.28e-05	0.000498	CcSEcCtD
Triamcinolone—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	2.26e-05	0.000495	CcSEcCtD
Triamcinolone—Cough—Mycophenolate mofetil—systemic scleroderma	2.25e-05	0.000491	CcSEcCtD
Triamcinolone—Dizziness—Captopril—systemic scleroderma	2.24e-05	0.00049	CcSEcCtD
Triamcinolone—Convulsion—Mycophenolate mofetil—systemic scleroderma	2.23e-05	0.000488	CcSEcCtD
Triamcinolone—Hypertension—Mycophenolate mofetil—systemic scleroderma	2.22e-05	0.000486	CcSEcCtD
Triamcinolone—Urticaria—Leflunomide—systemic scleroderma	2.22e-05	0.000485	CcSEcCtD
Triamcinolone—Body temperature increased—Leflunomide—systemic scleroderma	2.21e-05	0.000483	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Prednisone—systemic scleroderma	2.2e-05	0.000482	CcSEcCtD
Triamcinolone—Feeling abnormal—Mycophenolic acid—systemic scleroderma	2.19e-05	0.00048	CcSEcCtD
Triamcinolone—Myalgia—Mycophenolate mofetil—systemic scleroderma	2.19e-05	0.000479	CcSEcCtD
Triamcinolone—Myocardial infarction—Prednisone—systemic scleroderma	2.19e-05	0.000479	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Prednisone—systemic scleroderma	2.19e-05	0.000479	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	2.18e-05	0.000478	CcSEcCtD
Triamcinolone—Hypersensitivity—Azathioprine—systemic scleroderma	2.18e-05	0.000476	CcSEcCtD
Triamcinolone—Insomnia—Lisinopril—systemic scleroderma	2.17e-05	0.000474	CcSEcCtD
Triamcinolone—Discomfort—Mycophenolate mofetil—systemic scleroderma	2.17e-05	0.000474	CcSEcCtD
Triamcinolone—Paraesthesia—Lisinopril—systemic scleroderma	2.15e-05	0.000471	CcSEcCtD
Triamcinolone—Vomiting—Captopril—systemic scleroderma	2.15e-05	0.000471	CcSEcCtD
Triamcinolone—Dry mouth—Mycophenolate mofetil—systemic scleroderma	2.14e-05	0.000469	CcSEcCtD
Triamcinolone—Dyspnoea—Lisinopril—systemic scleroderma	2.14e-05	0.000468	CcSEcCtD
Triamcinolone—Rash—Captopril—systemic scleroderma	2.14e-05	0.000467	CcSEcCtD
Triamcinolone—Dermatitis—Captopril—systemic scleroderma	2.13e-05	0.000467	CcSEcCtD
Triamcinolone—Headache—Captopril—systemic scleroderma	2.12e-05	0.000464	CcSEcCtD
Triamcinolone—Dyspepsia—Lisinopril—systemic scleroderma	2.11e-05	0.000462	CcSEcCtD
Triamcinolone—Body temperature increased—Mycophenolic acid—systemic scleroderma	2.1e-05	0.00046	CcSEcCtD
Triamcinolone—Oedema—Mycophenolate mofetil—systemic scleroderma	2.1e-05	0.00046	CcSEcCtD
Triamcinolone—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	2.1e-05	0.00046	CcSEcCtD
Triamcinolone—Asthma—Methotrexate—systemic scleroderma	2.09e-05	0.000458	CcSEcCtD
Triamcinolone—Infection—Mycophenolate mofetil—systemic scleroderma	2.09e-05	0.000457	CcSEcCtD
Triamcinolone—Fatigue—Lisinopril—systemic scleroderma	2.07e-05	0.000452	CcSEcCtD
Triamcinolone—Shock—Mycophenolate mofetil—systemic scleroderma	2.07e-05	0.000452	CcSEcCtD
Triamcinolone—Hypersensitivity—Leflunomide—systemic scleroderma	2.06e-05	0.00045	CcSEcCtD
Triamcinolone—Pancreatitis—Methotrexate—systemic scleroderma	2.05e-05	0.000449	CcSEcCtD
Triamcinolone—Pain—Lisinopril—systemic scleroderma	2.05e-05	0.000449	CcSEcCtD
Triamcinolone—Tachycardia—Mycophenolate mofetil—systemic scleroderma	2.05e-05	0.000449	CcSEcCtD
Triamcinolone—Bradycardia—Prednisone—systemic scleroderma	2.04e-05	0.000446	CcSEcCtD
Triamcinolone—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	2.03e-05	0.000444	CcSEcCtD
Triamcinolone—Haemoglobin—Prednisone—systemic scleroderma	2.01e-05	0.000441	CcSEcCtD
Triamcinolone—Nausea—Captopril—systemic scleroderma	2.01e-05	0.00044	CcSEcCtD
Triamcinolone—Haemorrhage—Prednisone—systemic scleroderma	2e-05	0.000438	CcSEcCtD
Triamcinolone—Asthenia—Leflunomide—systemic scleroderma	2e-05	0.000438	CcSEcCtD
Triamcinolone—Feeling abnormal—Lisinopril—systemic scleroderma	1.98e-05	0.000432	CcSEcCtD
Triamcinolone—Pruritus—Leflunomide—systemic scleroderma	1.97e-05	0.000432	CcSEcCtD
Triamcinolone—Dizziness—Azathioprine—systemic scleroderma	1.95e-05	0.000427	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Methotrexate—systemic scleroderma	1.95e-05	0.000426	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	1.91e-05	0.000419	CcSEcCtD
Triamcinolone—Asthenia—Mycophenolic acid—systemic scleroderma	1.91e-05	0.000418	CcSEcCtD
Triamcinolone—Urticaria—Lisinopril—systemic scleroderma	1.91e-05	0.000417	CcSEcCtD
Triamcinolone—Insomnia—Mycophenolate mofetil—systemic scleroderma	1.9e-05	0.000416	CcSEcCtD
Triamcinolone—Body temperature increased—Lisinopril—systemic scleroderma	1.9e-05	0.000415	CcSEcCtD
Triamcinolone—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	1.89e-05	0.000413	CcSEcCtD
Triamcinolone—Pruritus—Mycophenolic acid—systemic scleroderma	1.88e-05	0.000412	CcSEcCtD
Triamcinolone—Vomiting—Azathioprine—systemic scleroderma	1.88e-05	0.000411	CcSEcCtD
Triamcinolone—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	1.87e-05	0.00041	CcSEcCtD
Triamcinolone—Rash—Azathioprine—systemic scleroderma	1.86e-05	0.000408	CcSEcCtD
Triamcinolone—Dermatitis—Azathioprine—systemic scleroderma	1.86e-05	0.000407	CcSEcCtD
Triamcinolone—Headache—Azathioprine—systemic scleroderma	1.85e-05	0.000405	CcSEcCtD
Triamcinolone—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	1.85e-05	0.000405	CcSEcCtD
Triamcinolone—Dizziness—Leflunomide—systemic scleroderma	1.85e-05	0.000404	CcSEcCtD
Triamcinolone—Conjunctivitis—Methotrexate—systemic scleroderma	1.81e-05	0.000397	CcSEcCtD
Triamcinolone—Pain—Mycophenolate mofetil—systemic scleroderma	1.8e-05	0.000393	CcSEcCtD
Triamcinolone—Arrhythmia—Prednisone—systemic scleroderma	1.79e-05	0.000392	CcSEcCtD
Triamcinolone—Vomiting—Leflunomide—systemic scleroderma	1.77e-05	0.000388	CcSEcCtD
Triamcinolone—Hypersensitivity—Lisinopril—systemic scleroderma	1.77e-05	0.000386	CcSEcCtD
Triamcinolone—Dizziness—Mycophenolic acid—systemic scleroderma	1.76e-05	0.000385	CcSEcCtD
Triamcinolone—Epistaxis—Methotrexate—systemic scleroderma	1.76e-05	0.000385	CcSEcCtD
Triamcinolone—Rash—Leflunomide—systemic scleroderma	1.76e-05	0.000385	CcSEcCtD
Triamcinolone—Dermatitis—Leflunomide—systemic scleroderma	1.76e-05	0.000385	CcSEcCtD
Triamcinolone—Nausea—Azathioprine—systemic scleroderma	1.76e-05	0.000384	CcSEcCtD
Triamcinolone—Headache—Leflunomide—systemic scleroderma	1.75e-05	0.000382	CcSEcCtD
Triamcinolone—Erythema—Prednisone—systemic scleroderma	1.75e-05	0.000382	CcSEcCtD
Triamcinolone—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	1.73e-05	0.000379	CcSEcCtD
Triamcinolone—Asthenia—Lisinopril—systemic scleroderma	1.72e-05	0.000376	CcSEcCtD
Triamcinolone—Pruritus—Lisinopril—systemic scleroderma	1.7e-05	0.000371	CcSEcCtD
Triamcinolone—Vomiting—Mycophenolic acid—systemic scleroderma	1.69e-05	0.00037	CcSEcCtD
Triamcinolone—Haemoglobin—Methotrexate—systemic scleroderma	1.68e-05	0.000368	CcSEcCtD
Triamcinolone—Rash—Mycophenolic acid—systemic scleroderma	1.68e-05	0.000367	CcSEcCtD
Triamcinolone—Dermatitis—Mycophenolic acid—systemic scleroderma	1.68e-05	0.000367	CcSEcCtD
Triamcinolone—Haemorrhage—Methotrexate—systemic scleroderma	1.68e-05	0.000366	CcSEcCtD
Triamcinolone—Urticaria—Mycophenolate mofetil—systemic scleroderma	1.67e-05	0.000365	CcSEcCtD
Triamcinolone—Headache—Mycophenolic acid—systemic scleroderma	1.67e-05	0.000365	CcSEcCtD
Triamcinolone—Pharyngitis—Methotrexate—systemic scleroderma	1.66e-05	0.000364	CcSEcCtD
Triamcinolone—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	1.66e-05	0.000363	CcSEcCtD
Triamcinolone—Nausea—Leflunomide—systemic scleroderma	1.66e-05	0.000363	CcSEcCtD
Triamcinolone—Ill-defined disorder—Prednisone—systemic scleroderma	1.62e-05	0.000354	CcSEcCtD
Triamcinolone—Angioedema—Prednisone—systemic scleroderma	1.59e-05	0.000349	CcSEcCtD
Triamcinolone—Dizziness—Lisinopril—systemic scleroderma	1.59e-05	0.000347	CcSEcCtD
Triamcinolone—Nausea—Mycophenolic acid—systemic scleroderma	1.58e-05	0.000346	CcSEcCtD
Triamcinolone—Malaise—Prednisone—systemic scleroderma	1.57e-05	0.000344	CcSEcCtD
Triamcinolone—Vertigo—Prednisone—systemic scleroderma	1.57e-05	0.000343	CcSEcCtD
Triamcinolone—Syncope—Prednisone—systemic scleroderma	1.57e-05	0.000342	CcSEcCtD
Triamcinolone—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	1.55e-05	0.000339	CcSEcCtD
Triamcinolone—Loss of consciousness—Prednisone—systemic scleroderma	1.53e-05	0.000335	CcSEcCtD
Triamcinolone—Vomiting—Lisinopril—systemic scleroderma	1.52e-05	0.000334	CcSEcCtD
Triamcinolone—Rash—Lisinopril—systemic scleroderma	1.51e-05	0.000331	CcSEcCtD
Triamcinolone—Convulsion—Prednisone—systemic scleroderma	1.51e-05	0.000331	CcSEcCtD
Triamcinolone—Dermatitis—Lisinopril—systemic scleroderma	1.51e-05	0.00033	CcSEcCtD
Triamcinolone—Asthenia—Mycophenolate mofetil—systemic scleroderma	1.51e-05	0.00033	CcSEcCtD
Triamcinolone—Hypertension—Prednisone—systemic scleroderma	1.51e-05	0.00033	CcSEcCtD
Triamcinolone—Headache—Lisinopril—systemic scleroderma	1.5e-05	0.000329	CcSEcCtD
Triamcinolone—Pruritus—Mycophenolate mofetil—systemic scleroderma	1.49e-05	0.000325	CcSEcCtD
Triamcinolone—Myalgia—Prednisone—systemic scleroderma	1.49e-05	0.000325	CcSEcCtD
Triamcinolone—Discomfort—Prednisone—systemic scleroderma	1.47e-05	0.000321	CcSEcCtD
Triamcinolone—Erythema—Methotrexate—systemic scleroderma	1.46e-05	0.000319	CcSEcCtD
Triamcinolone—Dysgeusia—Methotrexate—systemic scleroderma	1.43e-05	0.000312	CcSEcCtD
Triamcinolone—Nausea—Lisinopril—systemic scleroderma	1.42e-05	0.000312	CcSEcCtD
Triamcinolone—Oedema—Prednisone—systemic scleroderma	1.42e-05	0.000312	CcSEcCtD
Triamcinolone—Anaphylactic shock—Prednisone—systemic scleroderma	1.42e-05	0.000312	CcSEcCtD
Triamcinolone—Infection—Prednisone—systemic scleroderma	1.41e-05	0.000309	CcSEcCtD
Triamcinolone—Back pain—Methotrexate—systemic scleroderma	1.41e-05	0.000309	CcSEcCtD
Triamcinolone—Shock—Prednisone—systemic scleroderma	1.4e-05	0.000306	CcSEcCtD
Triamcinolone—Tachycardia—Prednisone—systemic scleroderma	1.39e-05	0.000304	CcSEcCtD
Triamcinolone—Dizziness—Mycophenolate mofetil—systemic scleroderma	1.39e-05	0.000304	CcSEcCtD
Triamcinolone—Hyperhidrosis—Prednisone—systemic scleroderma	1.38e-05	0.000301	CcSEcCtD
Triamcinolone—Ill-defined disorder—Methotrexate—systemic scleroderma	1.35e-05	0.000296	CcSEcCtD
Triamcinolone—Vomiting—Mycophenolate mofetil—systemic scleroderma	1.34e-05	0.000292	CcSEcCtD
Triamcinolone—Rash—Mycophenolate mofetil—systemic scleroderma	1.32e-05	0.00029	CcSEcCtD
Triamcinolone—Dermatitis—Mycophenolate mofetil—systemic scleroderma	1.32e-05	0.00029	CcSEcCtD
Triamcinolone—Headache—Mycophenolate mofetil—systemic scleroderma	1.32e-05	0.000288	CcSEcCtD
Triamcinolone—Malaise—Methotrexate—systemic scleroderma	1.32e-05	0.000288	CcSEcCtD
Triamcinolone—Vertigo—Methotrexate—systemic scleroderma	1.31e-05	0.000287	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Prednisone—systemic scleroderma	1.3e-05	0.000284	CcSEcCtD
Triamcinolone—Insomnia—Prednisone—systemic scleroderma	1.29e-05	0.000282	CcSEcCtD
Triamcinolone—Paraesthesia—Prednisone—systemic scleroderma	1.28e-05	0.00028	CcSEcCtD
Triamcinolone—Cough—Methotrexate—systemic scleroderma	1.27e-05	0.000278	CcSEcCtD
Triamcinolone—Convulsion—Methotrexate—systemic scleroderma	1.26e-05	0.000276	CcSEcCtD
Triamcinolone—Dyspepsia—Prednisone—systemic scleroderma	1.25e-05	0.000274	CcSEcCtD
Triamcinolone—Nausea—Mycophenolate mofetil—systemic scleroderma	1.25e-05	0.000273	CcSEcCtD
Triamcinolone—Myalgia—Methotrexate—systemic scleroderma	1.24e-05	0.000272	CcSEcCtD
Triamcinolone—Fatigue—Prednisone—systemic scleroderma	1.23e-05	0.000269	CcSEcCtD
Triamcinolone—Discomfort—Methotrexate—systemic scleroderma	1.23e-05	0.000268	CcSEcCtD
Triamcinolone—Anaphylactic shock—Methotrexate—systemic scleroderma	1.19e-05	0.00026	CcSEcCtD
Triamcinolone—Infection—Methotrexate—systemic scleroderma	1.18e-05	0.000259	CcSEcCtD
Triamcinolone—Feeling abnormal—Prednisone—systemic scleroderma	1.17e-05	0.000257	CcSEcCtD
Triamcinolone—Hyperhidrosis—Methotrexate—systemic scleroderma	1.15e-05	0.000252	CcSEcCtD
Triamcinolone—Urticaria—Prednisone—systemic scleroderma	1.13e-05	0.000247	CcSEcCtD
Triamcinolone—Body temperature increased—Prednisone—systemic scleroderma	1.13e-05	0.000246	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	1.08e-05	0.000237	CcSEcCtD
Triamcinolone—Insomnia—Methotrexate—systemic scleroderma	1.08e-05	0.000235	CcSEcCtD
Triamcinolone—Paraesthesia—Methotrexate—systemic scleroderma	1.07e-05	0.000234	CcSEcCtD
Triamcinolone—Dyspnoea—Methotrexate—systemic scleroderma	1.06e-05	0.000232	CcSEcCtD
Triamcinolone—Hypersensitivity—Prednisone—systemic scleroderma	1.05e-05	0.00023	CcSEcCtD
Triamcinolone—Dyspepsia—Methotrexate—systemic scleroderma	1.05e-05	0.000229	CcSEcCtD
Triamcinolone—Fatigue—Methotrexate—systemic scleroderma	1.03e-05	0.000224	CcSEcCtD
Triamcinolone—Asthenia—Prednisone—systemic scleroderma	1.02e-05	0.000224	CcSEcCtD
Triamcinolone—Pain—Methotrexate—systemic scleroderma	1.02e-05	0.000223	CcSEcCtD
Triamcinolone—Pruritus—Prednisone—systemic scleroderma	1.01e-05	0.00022	CcSEcCtD
Triamcinolone—Feeling abnormal—Methotrexate—systemic scleroderma	9.81e-06	0.000215	CcSEcCtD
Triamcinolone—Urticaria—Methotrexate—systemic scleroderma	9.46e-06	0.000207	CcSEcCtD
Triamcinolone—Dizziness—Prednisone—systemic scleroderma	9.42e-06	0.000206	CcSEcCtD
Triamcinolone—Body temperature increased—Methotrexate—systemic scleroderma	9.41e-06	0.000206	CcSEcCtD
Triamcinolone—Vomiting—Prednisone—systemic scleroderma	9.06e-06	0.000198	CcSEcCtD
Triamcinolone—Rash—Prednisone—systemic scleroderma	8.98e-06	0.000196	CcSEcCtD
Triamcinolone—Dermatitis—Prednisone—systemic scleroderma	8.97e-06	0.000196	CcSEcCtD
Triamcinolone—Headache—Prednisone—systemic scleroderma	8.92e-06	0.000195	CcSEcCtD
Triamcinolone—Hypersensitivity—Methotrexate—systemic scleroderma	8.77e-06	0.000192	CcSEcCtD
Triamcinolone—Asthenia—Methotrexate—systemic scleroderma	8.54e-06	0.000187	CcSEcCtD
Triamcinolone—Nausea—Prednisone—systemic scleroderma	8.46e-06	0.000185	CcSEcCtD
Triamcinolone—Pruritus—Methotrexate—systemic scleroderma	8.42e-06	0.000184	CcSEcCtD
Triamcinolone—Dizziness—Methotrexate—systemic scleroderma	7.87e-06	0.000172	CcSEcCtD
Triamcinolone—Vomiting—Methotrexate—systemic scleroderma	7.57e-06	0.000166	CcSEcCtD
Triamcinolone—Rash—Methotrexate—systemic scleroderma	7.51e-06	0.000164	CcSEcCtD
Triamcinolone—Dermatitis—Methotrexate—systemic scleroderma	7.5e-06	0.000164	CcSEcCtD
Triamcinolone—Headache—Methotrexate—systemic scleroderma	7.46e-06	0.000163	CcSEcCtD
Triamcinolone—Nausea—Methotrexate—systemic scleroderma	7.07e-06	0.000155	CcSEcCtD
